Showing 1,021 - 1,040 results of 102,731 for search '(( e point decrease ) OR ( 5 ((((nn decrease) OR (a decrease))) OR (we decrease)) ))', query time: 1.00s Refine Results
  1. 1021
  2. 1022

    Macroalgae Decrease Growth and Alter Microbial Community Structure of the Reef-Building Coral, <em>Porites astreoides</em> by Rebecca Vega Thurber (41633)

    Published 2012
    “…To determine if macroalgae alter the coral microbiome, we conducted a field-based experiment in which the coral <em>Porites astreoides</em> was placed in competition with five species of macroalgae. …”
  3. 1023
  4. 1024
  5. 1025

    Nef Decreases HIV-1 Sensitivity to Neutralizing Antibodies that Target the Membrane-proximal External Region of TMgp41 by Rachel P.J. Lai (193116)

    Published 2011
    “…While exploring the mechanism by which Nef increases the infectivity of cell-free virions, we investigated a functional link between Nef and Env. …”
  6. 1026
  7. 1027
  8. 1028
  9. 1029
  10. 1030

    Decreased MCM2-6 in Drosophila S2 Cells Does Not Generate Significant DNA Damage or Cause a Marked Increase in Sensitivity to Replication Interference by Isabelle Crevel (119003)

    Published 2011
    “…<div><p>A reduction in the level of some MCM proteins in human cancer cells (MCM5 in U20S cells or MCM3 in Hela cells) causes a rapid increase in the level of DNA damage under normal conditions of cell proliferation and a loss of viability when the cells are subjected to replication interference. …”
  11. 1031

    Decreasing ShcA expression enhances TGF-β-induced Smad signaling. by Baby Periyanayaki Muthusamy (838234)

    Published 2015
    “…Note the enhanced basal pSmad3 or pSmad2 levels in cells transfected with ShcA siRNA. ShcA immunoblotting reveals decreased ShcA levels in cells transfected with ShcA siRNA, and GAPDH immunoblotting serves as loading control. …”
  12. 1032
  13. 1033

    Decreased antihyperglycemic drug use driven by high out-of-pocket costs despite Medicare coverage gap closure by Mugdha Gokhale (8676201)

    Published 2020
    “…<a><b>Objectives</b></a>: <a>Using the 2016 Medicare part D coverage gap as an example, we explored effects of increased out-of-pocket costs on adherence to branded </a>dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients without financial subsidies, relative to subsidized patients who do not experience increased spending during the gap. …”
  14. 1034
  15. 1035
  16. 1036
  17. 1037
  18. 1038
  19. 1039
  20. 1040